NCT07597551

Brief Summary

The aim of this study is to compare the efficacy of the ultrasound- guided pericapsular nerve group (PENG) block versus the femoral nerve block (FNB) for postoperative pain control in patients undergoing hip surgeries, specifically evaluating pain scores and quadriceps strength.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
May 2026May 2027

First Submitted

Initial submission to the registry

January 24, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

May 15, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2027

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

January 24, 2026

Last Update Submit

May 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS) Score for Pain at 24 Hours.

    A scale from 0 to 10 (0 = no pain, 10 = worst imaginable pain). Patients will be asked to rate their pain level at rest.

    24 hours postoperatively.

Secondary Outcomes (2)

  • Quadriceps Muscle Strength

    6, 12, and 24 hours post-op.

  • Total Opioid Consumptiont

    First 3 days

Study Arms (2)

PENG block group

EXPERIMENTAL

Participants in this group will receive a preoperative, ultrasound-guided Pericapsular Nerve Group (PENG) block. Under sterile conditions and ultrasound guidance (curvilinear or linear probe), the needle will be inserted in-plane to target the facial plane between the psoas tendon and the pubic ramus. A volume of 20-25 mL of 0.25% Bupivacaine will be injected following negative aspiration

Procedure: PENG BLOCK

Femoral nerve block group

ACTIVE COMPARATOR

Participants in this group will receive a preoperative, ultrasound-guided Femoral Nerve Block (FNB). Using a linear probe, the femoral nerve will be identified lateral to the femoral artery and deep to the fascia iliaca. A volume of 20-25 mL of 0.25% Bupivacaine will be injected to achieve circumferential spread around the nerve trunk

Procedure: Femoral nerve block

Interventions

PENG BLOCKPROCEDURE

Regional anesthesia technique involving the injection of local anesthetic into the myofascial plane between the psoas muscle and the iliopubic eminence.

Also known as: Pericapsular Nerve Group block
PENG block group

Regional anesthesia technique involving the injection of local anesthetic deep to facia iliaca and lateral to femoral artery circulating femoral nerve trunk.

Also known as: FNB
Femoral nerve block group

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 40 years or older.
  • Presenting for hip surgeries
  • No contraindications to regional anesthesia.
  • Time of surgery up to 3 hours
  • ASA I-III
  • Able to provide written informed consent.
  • Able to reliably report pain and other symptoms to the research team.
  • Undergoing elective or emergency hip surgeries.

You may not qualify if:

  • Inability to provide first-person consent due to cognitive impairment.
  • Presence of a language barrier that would preclude reliable reporting of symptoms or understanding study procedures.
  • More than ASA III. 4
  • Previous neurological deficit in the lower limbs.
  • Local infection at block area.
  • Lengthy surgeries more than 3 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Taghreed Saker, MD

    Benha University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed I Swera, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized into two distinct groups. Group A: Receives the PENG block. Group B: Receives the Femoral Nerve Block (FNB). Flow: Each patient stays in their assigned group for the duration of the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant lecetruer

Study Record Dates

First Submitted

January 24, 2026

First Posted

May 19, 2026

Study Start

May 15, 2026

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

May 15, 2027

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share